Introduction: Intradural extramedullary (IDEM) spinal cord tumours account two thirds of all intraspinal tumours. The objective of this study was to determine short- and long-term outcomes of surgical patients with IDEM spinal cord tumours, and to see clinical features that could be helpful in management of patients with these lesions (operated by single senior surgeononly).
Methods: A retrospective review of 201 operative IDEM spinal cord tumours cases between 1993 and 2014 was performed. Outcomes were scored at one month and at mean follow-up of 8.5 months postoperatively. In addition, patient demographics, tumour types and locations were also collected. Statistical analysis was conducted utilizing Chi-square and Student's t-tests.
Results: There were 93 men and 108 women (mean age 48 yrs, range 5-87 yrs). Men presented at a younger age than women (42 vs 51 yrs, P<0.02). 165 (82.08 %) patients presented with severe radiculopathy and myelopathy. The 36 (17.91 %) had symptoms of radiculopathy. Mean duration of symptoms prior to diagnosis was 11 months. Schwannomas (113 patients) had the longest mean duration of symptoms (14.9 months), followed by meningiomas (68 patients, 8.4 months), and ependymomas (20 patients, 2 months). Hundred and eighty nine (94%) of patients demonstrated significant improvement at one-month and 186 (92%) at 6-month mean follow-up. Only 39/201 (19.4%) patients had residual focal deficits on long term follow-up.
Conclusions: Surgery for IDEM should be expected to produce significant and dramatic improvement in most of patients. Demographic, tumor-specific and anatomic considerations will be clinically useful while managing IDEM.
1. Abul-Kasim K, Thurnher MM, McKeever P, Sundgren PC. Intradural spinal tumours: Current classification and MRI features. Neuroradiology 2008;50:301-14.
2. Allen JC, Aviner S, Yates AJ, Boyett JM, Cherlow JM, Turski PA, et al. Treatment of high-grade spinal cord astrocytoma of children with “8 in 1” chemotherapy and radiotherapy: a pilot study of CCG-945. Children's Cancer Group. J Neurosurg. 1998;88:215-220.
3. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-4.
4. Cohen AR, Wisoff JH, Allen JC, Epstein F. Malignant astrocytomas of the spinal cord. J Neurosurg. 1989;70:50-54.
5. Cohen-Gadol AA, Zikel OM, Koch CA, Scheithauer BW, Krauss WE. Spinal menin giomas in patients younger than 50 years of age: a 21-year experience. J Neurosurg. 2003;98:258-63.
6. Duong LM, McCarthy BJ, McLendon RE, Dolecek TA, Kruchko C, Douglas LL, et al. Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004–2007. Cancer 2012;118:4220-7.
7. el-Mahdy W, Kane PJ, Powell MP, Crockard HA: Spinal intradural tumors: Part I - Extramedullary. Br J Neurosurg. 1999;13:550-557.
8. Fromme K, Miltner FO, Klawki P, Friedrich M. Spinal cord monitoring during intraspinal extramedullary tumor operations (peroneal nerve evoked responses). Neurosurg Rev. 1990;13:195-9.
9. Gelabert-Gonzalez M, Garcia-Allut A, Martinez-Rumbo R. Spinal meningiomas. Neurocirurgia (Astur). 2006;17:125-131.
10. Garrido P, Laher-Mooncey S, Murphree NL, Jonker N, Levy LF, and Makarawo S. Neoplasms involving the spinal cord in Zimbabweans: an analysis of 262 cases. Cent Afr J Med. 1994;40:201-204.
11. Gelabert-Gonzalez M. Primary spinal cord tumors. An analysis of a series of 168 patients. Rev Neurol. 2007;44:269-274.
12. Helseth A, Mørk SJ (1989) Primary intraspinal neoplasms in Norway, 1955 to 1986: a population-based survey of 467 patients. Journal of neurosurgery. 71(6): 842–845.
13. Hufana V, Tan JSH, Tan KK. Microsurgical treatment for spinal tumors. Singapore med J. 2005;46:74-77.
14. Kobayashi S, Uchida K, Kokubo Y, Yayama T, Nakajima H, et al. (2007) A schwannoma of the S1 dural sleeve was resected while the intact nerve fibers were preserved using a microscope. Report of a case with early MRI findings. Minimal Invasive Neurosurgery. 50(2): 120–123.
15. Nurick S. The pathogenesis of the spinal cord disorder associated with cervical spondylosis. Brain 1972; 95:87-100.
16. Odom GL, Finney W, Woodhall B. Cervical disk lesions. JAMA. 1958;166:23-28.
17. Osbom AG. Handbook of neuroradiology. St Louis: Mosby; 1991. p. 380-2.
18. Porchet F, Sajadi A, Villemure JG. Spinal tumors: clinical aspects, classification and surgical treatment. Schweiz Rundsch Med Prax. 2003;92:1897-1905.
19. Prevedello DM, Koerbel A, Tatsui CE, Truite L, Grande CV, Ditzel LF, Araujo JC. Prognostic factors in the treatment of the intradural extramedullary tumors: a study of 44 cases. Arq Neuropsiquiatr. 2003;61:241-247.
20. Queckel LG, Versteege CW. The “dural tail sign” in MRI of spinal meningiomas. J Comput Assist Tomogr. 1995;19:890-2.
21. Sandalcioglu IE, Gasser T, Asgari S, Lazorisak A, Engelhorn T, Egelhof T, Stolke D, Wiedemayer H. Functional outcome after surgical treatment of intramedullary spinal cord tumors: experience with 78 patients. Spinal Cord. 2005;43:34-41.
22. Seppälä MT, Haltia MJ, Sankila RJ, Jääskeläinen JE, Heiskanen O. Long-term outcome after removal of spinal schwannoma: A clinicopathological study of 187 cases. J Neurosurg 1995;83:621-6.
23. Souweidane MM, Benjamin V. Spinal cord meningiomas. Neurosurg Clin North Am. 1994;5:283-291.
24. Wippold FJ 2nd, Smirniotopoulos JG, Moran CJ, Suojanen JN, Vollmer DG. MR imaging of myxopapillary ependymoma: findings and value to determine extent of tumor and its relation to intraspinal structures. AJR Am J Roentgenol. 1995;165:1263-7.